Centenial Surgical Suture Ltd.

Healthcare · Healthcare Equipment & Supplies

BSE: 531380
₹102.85
▲ 3.09 (3.10%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
42/100
Moderate
Valuation
94/100
Undervalued
Momentum
69/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹38 Cr
PE (TTM)
Data unavailable.
Price to Book
1.3
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-21.0
Free Cash Flow
₹2 Cr
as of March 31, 2026
Industry median ₹-4 Cr (17 companies)
EPS Growth (YoY)
1927.27%
as of June 30, 2026
Industry median 27.06% (10 companies)
Net Profit Growth (TTM)
-212.55%
as of June 30, 2026
Industry median 12.23% (8 companies)
Operating Revenue Growth (TTM)
6.70%
as of June 30, 2026
Industry median 8.86% (8 companies)
Profit Growth (YoY)
1984.62%
as of June 30, 2026
Industry median 24.77% (9 companies)
Revenue Growth (YoY)
18.61%
as of June 30, 2026
Industry median 12.25% (11 companies)
Current Ratio
1.90
as of March 31, 2026
Industry median 3.04 (17 companies)
Debt to Equity
0.38
as of March 31, 2026
Industry median 0.11 (12 companies)
Interest Coverage
0.68
as of June 30, 2026
Industry median 12.12 (11 companies)
Net Margin
4.79%
as of June 30, 2026
Industry median 5.41% (10 companies)
Operating Margin (EBIT)
8.29%
as of June 30, 2026
Industry median 9.40% (11 companies)
Operating Margin (TTM)
4.00%
as of June 30, 2026
Industry median 13.81% (11 companies)
Return on Assets
-2.78%
as of March 31, 2026
Industry median 4.45% (10 companies)
Return on Capital Employed
2.61%
as of March 31, 2026
Industry median 8.85% (11 companies)
Return on Equity
-7.77%
as of March 31, 2026
Industry median 2.26% (9 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.38)
  • No Return on equity is 15% or more (-7.8%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
3.1%
Low 102.8500 · High 104.0000
1W return
-2.0%
Low 99.7500 · High 105.0000
1M return
14.7%
Low 88.0000 · High 106.0400
52W return
-24.9%
Low 81.6300 · High 106.0400
Lifetime High ₹159.9500 (Oct. 9, 2023)
Lifetime Low ₹1.0500 (Dec. 18, 2007)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish1
5D
101.5
10D
100.2
20D
98.6
50D
99.8
100D
102.2
200D
104.9

Delivery and volume

Day avg. delivery
91.1%
Week avg. delivery
99.5%
Month avg. delivery
97.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

103.23
Pivot
First resistance103.62
Second resistance104.38
Third resistance104.77
First support102.47
Second support102.08
Third support101.32
Day RSI55.7
Day MFI50.1
Day MACD1.19
Day MACD signal0.08

Beta

1M0.63
3M0.05
1Y0.05
3Y0.25

Price change analysis

↑ 14.7%
Over 1 Month
LowHigh
88.00106.04
↓ -24.9%
Over 3 Months
LowHigh
81.63106.04
↓ -24.9%
Over 6 Months
LowHigh
81.63106.04
↓ -24.9%
Over 1 Year
LowHigh
81.63106.04
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹15 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹2.0100

Ranks #12 of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter46.89%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 46.89% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
27 Jun 2023 VIPUL NAVINCHANDRA SHAH Bulk Sell 28,849 64.1500 BSE
27 Jun 2023 VIJAY KALIDAS MAJREKAR Bulk Buy 51,326 64.1500 BSE
24 May 2023 VIPUL NAVINCHANDRA SHAH Bulk Buy 28,849 64.7500 BSE
24 May 2023 SHREE BHUVANAKARAM TRADINVEST PVT LTD Bulk Sell 28,849 64.7500 BSE
12 Oct 2015 VOLGA INTERNATIONAL LIMITED Bulk Sell 19,127 56.6500 BSE
25 Jul 2013 VIPUL RAJENDRABHAI GANDHI Bulk Sell 35,000 33.1500 BSE
25 Jul 2013 BHARTIBEN RAJENDRA GANDHI Bulk Sell 36,000 33.1500 BSE
25 Jul 2013 GANDHI RAJENDRA DHIRAJLAL Bulk Sell 36,000 33.1500 BSE
25 Jul 2013 HEMA RAJENDRABHAI GANDHI Bulk Sell 36,000 33.1500 BSE
25 Jul 2013 VIJAY KALIDAS MAJREKAR Bulk Buy 165,275 33.1500 BSE

All bulk and block deals →

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
19 Sep 2026 Insider Trading / SAST Centenial Surgical Suture Ltd - 531380 - Closure of Trading Window
11 Sep 2026 Company Update Centenial Surgical Suture Ltd - 531380 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.90)
  • Strong revenue growth YoY (18.6%)

Weaknesses

  • Low Return on Equity (-7.8%)
  • Thin net profit margin (4.8%)

Opportunities

Data unavailable.

Threats

  • Down 24.9% over the past year
  • Weak interest coverage (0.7x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Centenial Surgical Suture Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.